Found 957 results
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is B  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
D. Patel, Danelishvili, L., Yamazaki, Y., Alonso, M., Paustian, M. L., Bannantine, J. P., Meunier-Goddik, L., and Bermudez, L. E., The ability of Mycobacterium avium subsp. paratuberculosis to enter bovine epithelial cells is influenced by preexposure to a hyperosmolar environment and intracellular passage in bovine mammary epithelial cells., Infect Immun, vol. 74, no. 5, pp. 2849-55, 2006.
D. Patel, Danelishvili, L., Yamazaki, Y., Alonso, M., Paustian, M. L., Bannantine, J. P., Meunier-Goddik, L., and Bermudez, L. E., The ability of Mycobacterium avium subsp. paratuberculosis to enter bovine epithelial cells is influenced by preexposure to a hyperosmolar environment and intracellular passage in bovine mammary epithelial cells., Infection and immunity, vol. 74, no. 5, pp. 2849-55, 2006.
D. Patel, Danelishvili, L., Yamazaki, Y., Alonso, M., Paustian, M. L., Bannantine, J. P., Meunier-Goddik, L., and Bermudez, L. E., The ability of Mycobacterium avium subsp. paratuberculosis to enter bovine epithelial cells is influenced by preexposure to a hyperosmolar environment and intracellular passage in bovine mammary epithelial cells., Infect Immun, vol. 74, no. 5, pp. 2849-55, 2006.
D. Patel, Danelishvili, L., Yamazaki, Y., Alonso, M., Paustian, M. L., Bannantine, J. P., Meunier-Goddik, L., and Bermudez, L. E., The ability of Mycobacterium avium subsp. paratuberculosis to enter bovine epithelial cells is influenced by preexposure to a hyperosmolar environment and intracellular passage in bovine mammary epithelial cells., Infection and immunity, vol. 74, no. 5, pp. 2849-55, 2006.
Y. Yamazaki, Danelishvili, L., Wu, M., Hidaka, E., Katsuyama, T., Stang, B., Petrofsky, M., Bildfell, R., and Bermudez, L. E., The ability to form biofilm influences Mycobacterium avium invasion and translocation of bronchial epithelial cells., Cell Microbiol, vol. 8, no. 5, pp. 806-14, 2006.
Y. Yamazaki, Danelishvili, L., Wu, M., Hidaka, E., Katsuyama, T., Stang, B. V., Petrofsky, M., Bildfell, R. J., and Bermudez, L. E., The ability to form biofilm influences Mycobacterium avium invasion and translocation of bronchial epithelial cells., Cellular microbiology, vol. 8, no. 5, pp. 806-14, 2006.
Y. Yamazaki, Danelishvili, L., Wu, M., Hidaka, E., Katsuyama, T., Stang, B., Petrofsky, M., Bildfell, R., and Bermudez, L. E., The ability to form biofilm influences Mycobacterium avium invasion and translocation of bronchial epithelial cells., Cell Microbiol, vol. 8, no. 5, pp. 806-14, 2006.
Y. Yamazaki, Danelishvili, L., Wu, M., Hidaka, E., Katsuyama, T., Stang, B. V., Petrofsky, M., Bildfell, R. J., and Bermudez, L. E., The ability to form biofilm influences Mycobacterium avium invasion and translocation of bronchial epithelial cells., Cellular microbiology, vol. 8, no. 5, pp. 806-14, 2006.
N. Luckschander, Hall, J. A., Gaschen, F., Forster, U., Wenzlow, N., Hermann, P., Allenspach, K., Dobbelaere, D., Burgener, I. A., and Welle, M., Activation of nuclear factor-kappaB in dogs with chronic enteropathies., Vet Immunol Immunopathol, vol. 133, no. 2-4, pp. 228-36, 2010.
N. Luckschander, Hall, J. A., Gaschen, F., Forster, U., Wenzlow, N., Hermann, P., Allenspach, K., Dobbelaere, D., Burgener, I. A., and Welle, M., Activation of nuclear factor-kappaB in dogs with chronic enteropathies., Veterinary immunology and immunopathology, vol. 133, no. 2-4, pp. 228-36, 2010.
L. E. Bermudez and Young, L. S., Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex., Antimicrobial agents and chemotherapy, vol. 32, no. 8, pp. 1149-53, 1988.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Wu, M., Barbara-Burnham, L., and Young, L. S., Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice., Antimicrobial agents and chemotherapy, vol. 40, no. 3, pp. 546-51, 1996.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Wu, M., Barbara-Burnham, L., and Young, L. S., Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice., Antimicrobial agents and chemotherapy, vol. 40, no. 3, pp. 546-51, 1996.
C. B. Inderlied, Barbara-Burnham, L., Wu, M., Young, L. S., and Bermudez, L. E., Activities of the benzoxazinorifamycin KRM 1648 and ethambutol against Mycobacterium avium complex in vitro and in macrophages., Antimicrobial agents and chemotherapy, vol. 38, no. 8, pp. 1838-43, 1994.
C. B. Inderlied, Barbara-Burnham, L., Wu, M., Young, L. S., and Bermudez, L. E., Activities of the benzoxazinorifamycin KRM 1648 and ethambutol against Mycobacterium avium complex in vitro and in macrophages., Antimicrobial agents and chemotherapy, vol. 38, no. 8, pp. 1838-43, 1994.
L. E. Bermudez, Kolonoski, P., Young, L. S., and Inderlied, C. B., Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection., Antimicrobial agents and chemotherapy, vol. 38, no. 8, pp. 1844-8, 1994.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Petrofsky, M., Aralar, P., Wu, M., and Young, L. S., Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium., Antimicrobial agents and chemotherapy, vol. 45, no. 1, pp. 217-22, 2001.
C. K. Cebra, Cebra, M. L., Garry, F. B., Larsen, R. S., and Baxter, G. M., Acute gastrointestinal disease in 27 New World camelids: clinical and surgical findings., Veterinary surgery : VS, vol. 27, no. 2, pp. 112-21, 1998.
A. K. LeBlanc, Mazcko, C. N., Cherukuri, A., Berger, E. P., Kisseberth, W. C., Brown, M. E., Lana, S. E., Weishaar, K., Flesner, B. K., Bryan, J. N., Vail, D. M., Burton, J. H., Willcox, J. L., Mutsaers, A. J., J Woods, P., Northrup, N. C., Saba, C., Curran, K. M., Leeper, H., Wilson-Robles, H., Wustefeld-Janssens, B. G., Lindley, S., Smith, A. N., Dervisis, N., Klahn, S., Higginbotham, M. Lynn, Wouda, R. M., Krick, E., Mahoney, J. A., London, C. A., Barber, L. G., Balkman, C. E., McCleary-Wheeler, A. L., Suter, S. E., Martin, O., Borgatti, A., Burgess, K., Childress, M. O., Fidel, J. L., Allstadt, S. D., Gustafson, D. L., Selmic, L. E., Khanna, C., and Fan, T. M., Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs., Clin Cancer Res, 2021.

Pages